Amwell COO Kurt Knight, chief commercial growth officer Kathy Weiler to depart

Amwell (AMWL) has announced CFO Mark Hirschhorn will take on an expanded role as COO, effective Jan. 1, 2025. Hirschhorn will now oversee the company’s operational and growth strategies, including the clinical, sales and marketing teams, while continuing his responsibilities as CFO. Two executives will leave the company. chief commercial and growth officer Kathy Weiler, and COO Kurt Knight, will depart Amwell at the end of the year.